BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 23514988)

  • 1. Insights into atrial fibrillation.
    Mischke K; Knackstedt C; Marx N; Vollmann D
    Minerva Med; 2013 Apr; 104(2):119-30. PubMed ID: 23514988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in atrial fibrillation.
    Nattel S; Opie LH
    Lancet; 2006 Jan; 367(9506):262-72. PubMed ID: 16427496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhythm control in atrial fibrillation.
    Piccini JP; Fauchier L
    Lancet; 2016 Aug; 388(10046):829-40. PubMed ID: 27560278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: diagnosis and treatment.
    Gutierrez C; Blanchard DG
    Am Fam Physician; 2011 Jan; 83(1):61-8. PubMed ID: 21888129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anticoagulants for atrial fibrillation: a critical appraisal.
    Tzeis S; Andrikopoulos G
    Angiology; 2012 Apr; 63(3):164-70. PubMed ID: 22007032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
    Padanilam BJ; Prystowsky EN
    Med Clin North Am; 2008 Jan; 92(1):217-35, xii-xiii. PubMed ID: 18061006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.
    Falsetti L; Viticchi G; Tarquinio N; Silvestrini M; Capeci W; Balloni A; Catozzo V; Gentile A; Pellegrini F
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):636-41. PubMed ID: 24978663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
    Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of atrial fibrillation in the acute setting.
    Chenoweth J; Diercks DB
    Curr Opin Crit Care; 2012 Aug; 18(4):333-40. PubMed ID: 22622515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
    Trujillo TC; Dobesh PP; Crossley GH; Finks SW
    Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prevention in atrial fibrillation.
    Verheugt FW
    Neth J Med; 2006 Feb; 64(2):31-3. PubMed ID: 16517985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.